The purpose of the study is to evaluate the efficacy of the transcranial direct current stimulation of the primary motor cortex (M1) in patients affected by refractory chronic migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and medication-overuse headache (coded as 8.1) with migraine as primary headache.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
Change in headache days per months
Time frame: at 30, 60 and 90 days after the treatment
Change in drugs intake per months
Time frame: at 30, 60 and 90 days after treatment
Change in mean pain intensity score per months
Time frame: at 30, 60 and 90 days after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.